|
|
|
|
|
|
|
|
|
15.05.26 - 17:31
|
Pfizer Aktie: Trotz Umsatzplus weiter begrenztes Potenzial! (Aktiencheck)
|
|
|
New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Wolfe Research:
Wolfe-Research-Analystin Alexandria Hammond habe das Kursziel für die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol: PFE) leicht von 25 auf 26 USD angehoben, die Einstufung "underperform" jedoch bestätigt. [mehr]...
|
|
|
15.05.26 - 15:54
|
Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why (24/7 Wall St.)
|
|
|
Pfizer (NYSE:PFE) at $25.75, Molina Healthcare (NYSE:MOH) at $186.80, and Halliburton (NYSE:HAL) at $41.29 trade at defensive, cash-generative valuations. Michael Burry purchased these shares for their real earnings and margin stability, and with inflation still pressuring margins across the market, names that generate cash, hold pricing power, and trade at sober multiples carry a structural ... Michael Burry's Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why...
|
|
|
|
|
14.05.26 - 16:00
|
US Govt Settles With Former NYT Reporter In Biden/Twitter Censorship Case (ZeroHedge)
|
|
|
US Govt Settles With Former NYT Reporter In Biden/Twitter Censorship Case
Authored by Zachary Stieber via The Epoch Times,
The U.S. government has reached a settlement with a former New York Times reporter who was kicked off Twitter during the COVID-19 pandemic for posts about vaccines.
Officials in a settlement agreement dated May 11 and obtained by The Epoch Times said that the government “did in fact violate the First Amendment by exerting substantial coercive pressure on social media companies such as Twitter to suppress disfavored speech like Plaintiff's,” referring to former New York reporter Alex Berenson.
Officials said they were paying Berenson $150,000 to settle the case, which was filed in 2023 against then-President Joe Biden, Pfizer board member Dr. Scott Gottlieb, and others. In exchange, Berenson moved to dismiss the case.
“I'd like to thank the Trump administration for acknowledging the government's unconstitutional actions against me in 2021 and standing for my First ...
|
|
|
|
|
14.05.26 - 11:48
|
Pfizer receives EC approval for Hympavzi to treat haemophilia (PBR)
|
|
|
The approval covers adults and adolescents in the European Union (EU) who weigh at least 35kg and have haemophilia A (factor VIII deficiency) with factor VIII inhibitors, or
The post Pfizer receives EC approval for Hympavzi to treat haemophilia appeared first on Pharmaceutical Business review....
|
|
|
|
|
|
|
|
|
13.05.26 - 10:15
|
Pfizer-Aktie: Bleibt für Dividenden-Anleger attraktiv (Sharedeals)
|
|
|
Die Aktie von Pfizer hat in den vergangenen Monaten deutlich besser abgeschnitten als viele andere Werte aus dem Gesundheitssektor. Trotz anhaltender Skepsis gegenüber Pharmaunternehmen mehren sich die Hinweise darauf, dass die schwierigste Phase nach dem Ende des Corona-Booms überwunden sein könnte. Für Anleger von Pfizer waren die vergangenen Jahre alles andere als einfach. Während Technologieaktien […]
The post Pfizer-Aktie: Bleibt für Dividenden-Anleger attraktiv first appeared on sharedeals.de....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|